Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerro-alloy Resources Limited Regulatory News (FAR)

Share Price Information for Ferro-alloy Resources Limited (FAR)

Share Price is delayed by 15 minutes
Get Live Data
4.95    -0.05 (-1.00%)
Bid:
4.80
Ask:
5.10
Spread: 0.30 (6.25%)
Market Cap: £29.09m
FAR Live PriceLast checked at - London Stock Exchange

Intraday Ferro-alloy Resources Limited Share Chart

Appointment of Joint Broker

21 Feb 2022 07:00

RNS Number : 2017C
Ferro-Alloy Resources Limited
21 February 2022
 

 

21 February 2022

Ferro-Alloy Resources Limited ('FAR' or the 'Company' or the 'Group')

 

Appointment of Joint Broker

 

Ferro-Alloy Resources Limited (LSE:FAR), the vanadium producer and developer of the large Balasausqandiq vanadium deposit in Southern Kazakhstan, is pleased to announce the appointment of Liberum Capital Limited as a joint corporate broker alongside Shore Capital Stockbrokers Limited effective immediately.

 

 

 

For further information, visit www.ferro-alloy.com or contact:

 

Ferro-Alloy Resources Limited

Nick Bridgen (CEO)

info@ferro-alloy.com

 

Shore Capital

(Joint Corporate Broker)

Liberum Capital Limited

(Joint Corporate Broker)

Toby Gibbs/John More

 

Scott Mathieson/Lydia Zychowska

 

+44 207 408 4090

 

 

+44 20 3100 2000

 

St Brides Partners Limited

(Financial PR & IR Adviser)

Catherine Leftley/Ana Ribeiro

+44 207 236 1177

 

About Ferro Alloy Resources Limited:

The Company's operations are all located at the Balasausqandiq deposit in Kyzylordinskoye Oblast in the South of Kazakhstan. Currently the Company has two main business activities:

a) the high grade Balasausqandiq vanadium project (the "Project"); and

b) an existing vanadium concentrate processing operation (the "Existing Operation") 

Balasausqandiq is a very large deposit, with vanadium as the principal product together with several by-products. Owing to the nature of the ore, the capital and operating costs of development are very much lower than for other vanadium projects. 

A reserve on the JORC 2012 basis has been estimated only for the first ore-body (of five) which amounts to 23 million tonnes, not including the small amounts of near-surface oxidised material which is in the Inferred resource category. In the system of reserve estimation used in Kazakhstan the reserves are estimated to be over 70m tonnes in ore-bodies 1 to 5 but this does not include the full depth of ore-bodies 2 to 5. 

There is an existing concentrate processing operation at the site of the Balasausqandiq deposit. The production facilities were originally created from a 15,000 tonnes per year pilot plant which was then adapted to treat concentrates and expanded. Further expansion is being undertaken which is expected to result in annualised production capacity of around 1,500 tonnes of contained vanadium pentoxide plus significant by-product molybdenum. 

The strategy of the Company is to develop both the Project and the Existing Operation in parallel. Although they are located on the same site and use some of the same infrastructure, they are separate operations.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPBBLFLLLLBBBK
Date   Source Headline
6th May 20267:00 amRNSNon-Executive Director Share Sale
1st May 20267:00 amRNSGrant of Share Options
30th Apr 20267:00 amRNS2025 Final Results
1st Apr 20267:00 amRNSTotal Voting Rights & Admission of Shares
10th Mar 20267:00 amRNSIssue of Equity
19th Jan 20267:00 amRNSCarbon Black Substitute MOU
5th Dec 20257:00 amRNSIssue of Equity
14th Nov 20254:55 pmRNSResult of 2025 AGM
5th Nov 20257:00 amRNSIssue of Equity
4th Nov 20257:17 amRNSProject Finance Expression of Interest
13th Oct 20257:00 amRNSPositive Feasibility Study Results
9th Oct 20257:00 amRNSNotice of AGM
30th Sep 20257:00 amRNSInterim Results and feasibility study update
7th Jul 20257:00 amRNSIssue of Equity
27th Jun 20257:00 amRNSCBS Product Update and Feasibility Study Update
23rd Jun 20257:00 amRNSAppointment of Lead Financial Adviser
2nd Jun 20257:00 amRNSFramework Agreement for Phase 1 of Balasausqandiq
2nd May 20257:00 amRNSGrant of Share Options
30th Apr 20257:00 amRNS2024 Final Results
6th Mar 20257:00 amRNSIssue of Equity to Supplier
19th Dec 202412:10 pmRNSIssue of Equity to Directors & Share Subscription
17th Dec 20247:00 amRNSNon-Binding Offtake Term Sheet for Balasausqandiq
2nd Dec 20247:00 amRNSStrategic Focus on Carbon Black Substitute
29th Nov 20247:00 amRNSKazakhstan Exempt Offer Bond Programme Update
21st Nov 20247:00 amRNSCommercial Potential of Carbon Black Substitute
24th Oct 20247:00 amRNSQ3 2024 Production Results
23rd Oct 20244:52 pmRNSResult of 2024 AGM
26th Sep 20247:00 amRNSInterim Results
19th Sep 20247:00 amRNSNotice of AGM
18th Jul 20247:00 amRNSQ2 2024 Production Results
29th Apr 20247:00 amRNSFinal Results
26th Apr 20247:00 amRNSQ1 2024 Production Results
15th Feb 20241:00 pmRNSSale of 3rd Tranche of Exempt Offer Bond Programme
1st Feb 20247:00 amRNSFeasibility Study Update & Bond Programme
12th Jan 20247:00 amRNSQ4 2023 Production Results
22nd Dec 20237:00 amRNSTrading Update
30th Nov 20237:00 amRNSTotal Voting Rights
22nd Nov 20237:00 amRNSHolding(s) in Company
21st Nov 202312:17 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSIssue of Equity
1st Nov 20235:08 pmRNSResult of AGM
17th Oct 20237:00 amRNSExempt Offer Bond Programme - Second Tranche Sale
10th Oct 202312:53 pmRNSExisting Operation Q3 Production Results
6th Oct 20237:00 amRNSNotice of AGM
19th Sep 20237:00 amRNSExempt Offer Bond Programme - Second Tranche
12th Sep 20237:00 amRNSInvestor Presentation
12th Sep 20237:00 amRNSGrant of Share Options
11th Sep 20237:00 amRNSHalf-year Report
21st Aug 20237:00 amRNSTrading Update
27th Jul 20239:00 amRNSLaunch of Bond Programme /Listing of First Tranche

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.